Overview

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to assess the safety and efficacy of a simvastatin hydroxy acid injection (AM3101) to facilitate meniscal repair and reduce the incidence of non-healing complications and morbidities associated with a failed meniscal repair. This is a prospective, randomized, controlled, double-blinded, multi-center study.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
United States Department of Defense